Stay updated on Parpvax: Niraparib + Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Parpvax: Niraparib + Immunotherapy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the previous v3.4.2. This is a non-content update and does not affect study details or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-03-12T02:22:43.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new site revision banner shows Revision: v3.4.2, and the government funding status notice has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:18:49.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide lapse-in-funding notice about NIH Clinical Center operations with links to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1, replacing the previous v3.4.0 revision.
    Difference
    0.4%
    Check dated 2026-02-04T10:25:05.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new 'Show glossary' option appears on the Study Details page, and several small metadata/text updates were made (including Last Update Posted, capitalization in Last Update Submitted that Met QC Criteria, capitalization in No FEAR Act data, and Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T06:18:20.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3; no other changes to core content or trial details were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:37:44.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a new Locations section listing Pennsylvania as a study site. The HHS Vulnerability Disclosure link in the footer was removed.
    Difference
    0.2%
    Check dated 2025-12-23T16:56:50.000Z thumbnail image

Stay in the know with updates to Parpvax: Niraparib + Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.